Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Not yet recruiting · NCT06203821 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 1 | 2026-02-05 | NCT06203821 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aram Hezel | 1 |
| NETRIS Pharma | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Rochester | Rochester | United States | 360 |